RiverVest Venture Partners® focuses exclusively on innovations in life sciences, a field in which our team has significant research, clinical, operational and investment expertise.
Our team’s deep domain experience allows us to identify, found and actively incubate promising life science companies, particularly in the medical device and biopharmaceutical industries. We provide practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward.
RiverVest also invests in select later-stage life science companies to diversify risk and maximize portfolio returns. In every case, we take a hands-on investment approach, preferring to be represented on the boards of our portfolio companies.
Since its inception in September 2000, RiverVest has raised two investment funds with total committed capital of $164 million, and supported more than 20 innovative life science companies.
• Established in 2000
• $188 million under management
• More than 25 life science companies funded
• Six companies founded
• Nine exits